Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: Lung Cancer
USOR Number: 19208

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, MN 55125
P: (651) 735-7414

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Saint Paul

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: Lung Cancer
USOR Number: 19208

  • Practice Details

310 Smith Ave N
Suite 100
Saint Paul, MN 55102
P: (651) 251-5500

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: Lung Cancer
USOR Number: 19208

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, MN 55404
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: Lung Cancer
USOR Number: 19208

  • Practice Details

1580 Beam Avenue
Maplewood, MN 55109
P: (651) 779-7978

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Edina

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: Lung Cancer
USOR Number: 19208

  • Practice Details

6545 France Avenue, Suite 210
Edina, MN 55435
P: (952) 928-2900

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Randomized, Open-Label, Phase 3 Study of Pralsetinib versus Standard of Care for First Line Treatment of RET fusion-positive, Metastatic Non-Small Cell Lung Cancer (BLU-667-2303)

  • Details

ClinicalTrials.gov ID: NCT04222972
Diagnosis Type: Lung Cancer
USOR Number: 19208

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Saint Paul

A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF TIRAGOLUMAB, AN ANTI-TIGIT ANTIBODY,IN COMBINATION WITH ATEZOLIZUMAB COMPARED WITH PLACEBO IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PD-L1-SELECTED NON-SMALL CELL LUNG CANCER (GO41717)

  • Details

ClinicalTrials.gov ID: NCT04294810
Diagnosis Type: Lung Cancer
USOR Number: 19192

  • Practice Details

310 Smith Ave N
Suite 100
Saint Paul, MN 55102
P: (651) 251-5500

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF TIRAGOLUMAB, AN ANTI-TIGIT ANTIBODY,IN COMBINATION WITH ATEZOLIZUMAB COMPARED WITH PLACEBO IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PD-L1-SELECTED NON-SMALL CELL LUNG CANCER (GO41717)

  • Details

ClinicalTrials.gov ID: NCT04294810
Diagnosis Type: Lung Cancer
USOR Number: 19192

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, MN 55125
P: (651) 735-7414

More Details View Practice Page

Leukemia

Clinical Trial at: Minnesota Oncology - Coon Rapids

An Open Label Compassionate Use Trial of Ublituximab and/or Umbralisib (TGR-1202) in Combination with other Novel Agents or as Single Agents in Subjects Currently Receiving Treatment on a TG Therapeutics Study (UTX-TGR-501)

  • Details

ClinicalTrials.gov ID: NCT03207256
Diagnosis Type: Leukemia
USOR Number: 19198

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

A PHASE III, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF TIRAGOLUMAB, AN ANTI-TIGIT ANTIBODY,IN COMBINATION WITH ATEZOLIZUMAB COMPARED WITH PLACEBO IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PD-L1-SELECTED NON-SMALL CELL LUNG CANCER (GO41717)

  • Details

ClinicalTrials.gov ID: NCT04294810
Diagnosis Type: Lung Cancer
USOR Number: 19192

  • Practice Details

1580 Beam Avenue
Maplewood, MN 55109
P: (651) 779-7978

More Details View Practice Page
1 2 3 … 15

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.